Online inquiry

IVTScrip™ mRNA-Human ASAP1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25091MR)

This product GTTS-WK25091MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASAP1 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001247996.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 50807
UniProt ID Q9ULH1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASAP1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25091MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK5418MR IVTScrip™ mRNA-Human SOST, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA SOST
GTTS-WK12172MR IVTScrip™ mRNA-Human ACTR3, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ACTR3
GTTS-WK28692MR IVTScrip™ mRNA-Human ASAP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ASAP2
GTTS-WK10690MR IVTScrip™ mRNA-Human ADAM15, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADAM15
GTTS-WK24449MR IVTScrip™ mRNA-Human ARL6IP5, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARL6IP5
GTTS-WK12201MR IVTScrip™ mRNA-Human ADAMTS17, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADAMTS17
GTTS-WK14740MR IVTScrip™ mRNA-Human AJUBA, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AJUBA
GTTS-WK28111MR IVTScrip™ mRNA-Human ASGR2, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ASGR2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →